Annual FCF
-$80.87 M
-$1.86 M-2.35%
December 31, 2024
Summary
- As of March 13, 2025, ALGS annual free cash flow is -$80.87 million, with the most recent change of -$1.86 million (-2.35%) on December 31, 2024.
- During the last 3 years, ALGS annual FCF has risen by +$35.68 million (+30.61%).
- ALGS annual FCF is now -63.21% below its all-time high of -$49.55 million, reached on December 31, 2019.
Performance
ALGS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$18.43 M
+$1.70 M+8.43%
December 31, 2024
Summary
- As of March 13, 2025, ALGS quarterly free cash flow is -$18.43 million, with the most recent change of +$1.70 million (+8.43%) on December 31, 2024.
- Over the past year, ALGS quarterly FCF has increased by +$1.70 million (+8.43%).
- ALGS quarterly FCF is now -35.43% below its all-time high of -$13.61 million, reached on June 30, 2023.
Performance
ALGS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$80.87 M
+$4.23 M+4.97%
December 31, 2024
Summary
- As of March 13, 2025, ALGS TTM free cash flow is -$80.87 million, with the most recent change of +$4.23 million (+4.97%) on December 31, 2024.
- Over the past year, ALGS TTM FCF has increased by +$4.23 million (+4.97%).
- ALGS TTM FCF is now -277.75% below its all-time high of -$21.41 million, reached on March 31, 2020.
Performance
ALGS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALGS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.4% | +8.4% | +5.0% |
| 3 y3 years | +30.6% | +17.7% | +1.1% |
| 5 y5 years | -63.2% | +17.7% | +1.1% |
ALGS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.4% | +30.6% | -35.4% | +51.3% | -15.5% | +30.6% |
| 5 y | 5-year | -63.2% | +30.6% | -35.4% | +51.3% | -277.8% | +30.6% |
| alltime | all time | -63.2% | +30.6% | -35.4% | +51.3% | -277.8% | +30.6% |
Aligos Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$80.87 M(+2.4%) | -$18.43 M(-8.4%) | -$80.87 M(-5.0%) |
| Sep 2024 | - | -$20.13 M(+3.2%) | -$85.11 M(-0.3%) |
| Jun 2024 | - | -$19.50 M(-14.5%) | -$85.33 M(+7.4%) |
| Mar 2024 | - | -$22.82 M(+0.7%) | -$79.44 M(+0.5%) |
| Dec 2023 | -$79.02 M(-1.6%) | -$22.66 M(+11.4%) | -$79.02 M(+7.9%) |
| Sep 2023 | - | -$20.35 M(+49.5%) | -$73.22 M(+4.6%) |
| Jun 2023 | - | -$13.61 M(-39.2%) | -$70.02 M(-14.4%) |
| Mar 2023 | - | -$22.39 M(+32.7%) | -$81.78 M(+1.8%) |
| Dec 2022 | -$80.33 M | -$16.87 M(-1.6%) | -$80.33 M(-20.7%) |
| Sep 2022 | - | -$17.14 M(-32.4%) | -$101.27 M(-7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$25.37 M(+21.1%) | -$109.60 M(+2.0%) |
| Mar 2022 | - | -$20.95 M(-44.6%) | -$107.40 M(-7.9%) |
| Dec 2021 | -$116.55 M(+52.7%) | -$37.82 M(+48.5%) | -$116.55 M(+18.3%) |
| Sep 2021 | - | -$25.46 M(+9.9%) | -$98.48 M(+9.5%) |
| Jun 2021 | - | -$23.17 M(-23.0%) | -$89.93 M(+5.8%) |
| Mar 2021 | - | -$30.10 M(+52.5%) | -$85.02 M(+11.4%) |
| Dec 2020 | -$76.33 M(+54.0%) | -$19.75 M(+16.8%) | -$76.33 M(+34.9%) |
| Sep 2020 | - | -$16.91 M(-7.4%) | -$56.58 M(+42.6%) |
| Jun 2020 | - | -$18.26 M(-14.7%) | -$39.67 M(+85.3%) |
| Mar 2020 | - | -$21.41 M | -$21.41 M |
| Dec 2019 | -$49.55 M | - | - |
FAQ
- What is Aligos Therapeutics annual free cash flow?
- What is the all time high annual FCF for Aligos Therapeutics?
- What is Aligos Therapeutics annual FCF year-on-year change?
- What is Aligos Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly FCF year-on-year change?
- What is Aligos Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Aligos Therapeutics?
- What is Aligos Therapeutics TTM FCF year-on-year change?
What is Aligos Therapeutics annual free cash flow?
The current annual FCF of ALGS is -$80.87 M
What is the all time high annual FCF for Aligos Therapeutics?
Aligos Therapeutics all-time high annual free cash flow is -$49.55 M
What is Aligos Therapeutics annual FCF year-on-year change?
Over the past year, ALGS annual free cash flow has changed by -$1.86 M (-2.35%)
What is Aligos Therapeutics quarterly free cash flow?
The current quarterly FCF of ALGS is -$18.43 M
What is the all time high quarterly FCF for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly free cash flow is -$13.61 M
What is Aligos Therapeutics quarterly FCF year-on-year change?
Over the past year, ALGS quarterly free cash flow has changed by +$1.70 M (+8.43%)
What is Aligos Therapeutics TTM free cash flow?
The current TTM FCF of ALGS is -$80.87 M
What is the all time high TTM FCF for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM free cash flow is -$21.41 M
What is Aligos Therapeutics TTM FCF year-on-year change?
Over the past year, ALGS TTM free cash flow has changed by +$4.23 M (+4.97%)